Abstract |
Donor-derived hematologic malignancies are rare complications of hematopoietic cell transplantation (HCT). Although these are commonly either a myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML), in general, they are a heterogeneous group of diseases, and a unified mechanism for their development has remained elusive. Here we report next-generation sequencing, including whole-exome sequencing (WES), whole-genome sequencing (WGS), and targeted sequencing, of a case of donor-derived MDS (dMDS) following HCT for high-risk B- lymphoblastic leukemia (B-ALL) in an adolescent. Through interrogation of single-nucleotide polymorphisms (SNPs) in the WGS data, we unequivocally prove that the MDS is donor-derived. Additionally, we sequenced 15 samples from 12 time points, including the initial B-ALL diagnostic sample through several post-HCT remission samples, the dMDS, and representative germline samples from both patient and donor, to show that the MDS-related pathologic mutations, including a canonical ASXL1 (p.Y700*) mutation, were detectable nearly 3 yr prior to the morphological detection of MDS. Furthermore, these MDS mutations were not detectable immediately following, and for >1 yr post-, HCT. These data support the clinical utility of comprehensive sequencing following HCT to detect donor-derived malignancies, while providing insights into the clonal progression of dMDS over a 4-yr period.
|
Authors | Jason R Schwartz, Michael P Walsh, Jing Ma, Tamara Lamprecht, Shuoguo Wang, Gang Wu, Susana Raimondi, Brandon M Triplett, Jeffery M Klco |
Journal | Cold Spring Harbor molecular case studies
(Cold Spring Harb Mol Case Stud)
Vol. 4
Issue 5
(10 2018)
ISSN: 2373-2873 [Electronic] United States |
PMID | 29891567
(Publication Type: Case Reports, Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Copyright | © 2018 Schwartz et al.; Published by Cold Spring Harbor Laboratory Press. |
Chemical References |
- ASXL1 protein, human
- Repressor Proteins
|
Topics |
- Adolescent
- Adult
- Female
- Hematopoietic Stem Cell Transplantation
(adverse effects, methods)
- High-Throughput Nucleotide Sequencing
(methods)
- Humans
- Leukemia, Myeloid, Acute
(genetics, metabolism)
- Male
- Myelodysplastic Syndromes
(diagnosis, genetics)
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
(physiopathology, therapy)
- Repressor Proteins
(genetics)
- Tissue Donors
- Transplantation Conditioning
(methods)
- Transplantation, Homologous
(methods)
|